GlassScriptPhysician profile
Michael J Wilderman
NPI 1497802938
$383,122.94
in general payments reported to CMS, 2019-2025
24 companies · $31K in 2025
The $31K reported for 2025 was more than what 96% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83K · 2020: $31K · 2021: $57K · 2022: $71K · 2023: $80K · 2024: $31K · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $96K · Consulting Fee: $27K · Travel and Lodging: $12K · Food and Beverage: $6,928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $95,920.00 |
| Consulting Fee | $26,890.00 |
| Travel and Lodging | $12,032.58 |
| Food and Beverage | $6,927.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $285,740.80 | 2019-2025 | Zilver Ptx, Cook, Zenith Alpha |
| W. L. Gore & Associates, INC. | $47,272.22 | 2019-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Iliac Branch Endoprosthesis |
| Cook Medical LLC | $15,975.63 | 2019-2025 | Cook, Zenith Spiral-Z, Zilver Ptx |
| Getinge USA Sales, LLC | $10,000.00 | 2021 | |
| Vascular Technology, INC. | $8,600.00 | 2019-2020 | |
| Cvrx, INC. | $8,198.64 | 2020-2024 | Barostim Neo System |
| Ethicon INC. | $4,797.50 | 2021 | |
| Penumbra, INC. | $500.67 | 2022-2025 | Penumbra System, Indigo System, Ruby Coil |
| Medtronic, INC. | $393.23 | 2021-2024 | Symplicity G3 |
| Edwards Lifesciences Corporation | $370.16 | 2021-2022 | |
| Silk Road Medical, INC. | $250.08 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cardiva Medical, INC. | $165.75 | 2021-2022 | |
| Medtronic Vascular, INC. | $152.44 | 2019 | |
| Abiomed | $133.33 | 2024 | Impella |
| Cagent Vascular INC | $124.00 | 2025 | Serrantor |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $117.84 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Checkpoint Surgical, INC | $96.04 | 2022 | |
| Philips North America LLC | $87.59 | 2023 | |
| Thrombolex, INC. | $58.54 | 2024 | Bashir Endovascular Catheter |
| Bard Peripheral Vascular, INC. | $37.58 | 2024 | Denali Vena Cava Filter |
| Artivion, INC. | $27.91 | 2020-2021 | |
| Tactile Systems Technology INC | $17.39 | 2020 | |
| Boston Scientific Corporation | $5.60 | 2025 | Enroute Transcarotid Neuroprotection System |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wilderman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.